Takeda Escapes FCA Suit Over Undisclosed Drug Complications

Law360, New York (November 1, 2012, 8:44 PM EDT) -- A Massachusetts federal judge on Thursday stamped out False Claims Act allegations from an ex-contractor at Takeda Pharmaceutical Co. Ltd., saying the company's failure to disclose serious complications involving diabetes drug Actos, heartburn medicine Prevacid and other treatments doesn't mean it overbilled taxpayers.

Former Takeda medical reviewer Dr. Helen Ge laid out a solid basis for suspecting the Japan-based drugmaker underreported congestive heart failure linked to Actos and life-threatening drug-interaction problems in patients taking Prevacid, but she fell short when it came to showing the corporation...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.